Werewolf Therapeutics (HOWL) EBIT Margin (QoQ) (2022 - 2024)
Werewolf Therapeutics (HOWL) EBIT Margin (QoQ) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - |
| 10 | Werewolf Therapeutics | 43.45 Mn | 43.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 65,415.00 |
| Mar 31, 2024 | -142,391.00 |
| Dec 31, 2023 | -73,215.00 |
| Sep 30, 2023 | -8,180.00 |
| Jun 30, 2023 | 19,874.00 |
| Mar 31, 2023 | -9,283.00 |
| Dec 31, 2022 | 7,131.00 |
| Sep 30, 2022 | 10,865.00 |